John Vernon

University of North Carolina at Chapel Hill
Department of Health Policy & Management
1101C McGavran-Greenberg Hall
Chapel Hill, NC 27599-7411
Tel: 919/966-8930

E-Mail: no email available

NBER Working Papers and Publications

February 2010Generic Utilization Rates, Real Pharmaceutical Prices, and Research and Development Expenditures
with Joseph P. Cook, Graeme Hunter: w15723
April 2009What's the "Interest" in FDA Drug Advisory Committee Conflicts of Interest?
with Joseph Golec: w14932
November 2007Financial Risk in the Biotechnology Industry
with Joseph H. Golec: w13604

Published: Appl Health Econ Health Policy. 2009;7(3):155-65. doi: 10.2165/10899620-000000000-00000. Financial risk of the biotech industry versus the pharmaceutical industry.

December 2006Black Box Warnings and Drug Safety: Examining the Determinants and Timing of FDA Warning Labels
with Allan Begosh, John Goldsmith, Ed Hass, Randall W. Lutter, Clark Nardinelli: w12803
November 2006European Pharmaceutical Price Regulation, Firm Profitability, and R&D Spending
with Joseph H. Golec: w12676
December 2005The Future of Drug Development: The Economics of Pharmacogenomics
with W. Keener Hughen: w11875

Published: Vernon, J., Hughen K., Trujillo, A. The Future of Drug Development: The Economics of Pharmacogenomics. January 2008, Vol. 1, No. 1, Pages 49-59 Expert Review of Clinical Pharmacology

October 2005Race and Health Disparities Among Seniors in Urban Areas in Brazil
with Antonio J. Trujillo, Laura Rodriguez Wong, Gustavo Angeles: w11690

Published: Trujillo, Antonio J., John A. Vernon, Laura Rodriguez Wong, and Gustavo Angeles. "Race and Health Disparities Among Seniors in Urban Areas in Brazil." Journal of Aging and Health 21, 1 (2009): 3-37.

March 2005Pharmaceutical Stock Price Reactions to Price Constraint Threats and Firm-Level R&D Spending
with Joseph Golec, Shantaram Hegde: w11229
Hospital Ownership Mix Efficiency in the US: An Exploratory Study
with Rexford E. Santerre: w11192
February 2005Assessing Consumer Gains from a Drug Price Control Policy in the U.S.
with Rexford Santerre: w11139

Published: Santerre, Rexford E. and John A. Vernon. "Assessing Consumer Gains From A Drug Price Control Policy In The United States," Southern Economic Journal, 2006, v73(1,Jul), 233-245.

The Cost of US Pharmaceutical Price Reductions: A Financial Simulation Model of R&D Decisions
with Thomas A. Abbott: w11114

Published: Thomas A. Abbott & John A. Vernon, 2007. "The cost of US pharmaceutical price regulation: a financial simulation model of R&D decisions," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 293-306.

Testing for Ownership Mix Efficiency: The Case of the Nursing Home Industry
with Rexford E. Santerre: w11115
NBER Videos

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email:

Contact Us